ANTIMICROBIAL ACTIVITY OF [1,2,4]TRIAZOLO[4,3-а]PYRAZIN-8(7H)-ONE DERIVATIVES
Clicks: 268
ID: 58000
2014
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
16.2
/100
54 views
54 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Today the problem of microbial resistance to antibacterial
agents becomes the global one. Antimicrobial drugs that
are in the pharmaceutical market do not satisfy the needs
of modern treatment regimens, particularly Hospitalacquired
infections. Therefore, the search for new and effective means of this pharmacological group is an important task of medical chemistry. From the literature it is known that derivatives of [1,2,4]triazolo[4,3-a]pyrazine show a wide range of biological actions, including antimicrobial and fungicidal. This makes it
relevant microbiological study of primary derivatives of
[1,2,4]triazolo[4,3-a]pyrazine for identifying promising
compounds of the series and then study it in biological
experiment.Using the PASS C&T (Prediction Activity Spectra for Substances: Complex & Training) program and based on published data, we have generated virtual library of derivatives of [1,2,4]triazolo[4,3-a]pyrazine. As a result, we have received 35 new synthetic compounds of 7 series that were not previously described in the literature.
Materials and methods
The research of antimicrobial and fungicidal activity of
the synthesized compounds was carried out in the
laboratory of antimicrobial agents GA "Mechnikov
Institute of microbiology and immunology" under the
leadership of PhD, senior scientist V.V.Kazmirchuka.
The activity of the synthesized compounds were studied
by conventional method of the two-fold serial dilutions in
liquid and solid nutrient medium. For primary screening
we have used a set of clinical and reference strains of
microorganism: Escherichia coli ATCC 25922 (F-50),
Staphylococcus aureus ATCC 25923 (F-49), Bacillus
anthracoides ATCC 1312, Pseudomonas aeruginosa
ATCC 27853, Candida albicans ATCC 885-653. As the
reference preparations were chosen Palin - modern
antimicrobial agent of class of fluoroquinolones,
Nevigramon - nalidixic acid derivative and Fluconazole -38
Annals of Mechnikov Institute, N 4, 2014
www.imiamn.org.ua /journal.htm
modern antifungal agent. Activity of substances
determined by the minimum bacteriostatic (MBstK) and
minimal bactericidal (MBcK) concentrations. All
experiments were accompanied by appropriate controls.
Results and Discussion
As a result of microbiological screening of 35
compounds we have allowed to identify a number of
derivatives of [1,2,4]triazolo[4,3-a]pyrazine-8(7H)-one
with antimicrobial and antifungal activity. The most
pronounced effect showed compounds that contains in
their structure aryl moiety with halogen atom, or Narylatsetamide
group in position 3 or 2 of the heterocycle.
Principal condition for the demonstration of antifungal
activity is presence of Sulfur atom in the triazole cycle.
Conclusions
The substance of the series N 7
-aryl/benzyl-3-thioxo-
[1,2,4]triazolo[4,3-а]pyrazin-8(7H)-ones showed the best
antimicrobial and antifungal activity of all synthesized
compounds. Compound 7-(3-chloro-2-methyl-phenyl)-3-
thioxo-[1,2,4]triazolo[4,3-а]pyrazin-8(7Н)-one 4{4}
showed high values of antimicrobial activity against
gram-negative microorganisms (МBstК – 12.5-25.0
mkg/ml, МBcК – 25.0-50.0 mkg/ml) and was the most
promising for further development.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (438 words).
Try re-searching for a better abstract.
| Reference Key |
yu2014antimicrobialanali
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Yu., Kulikovska K.;G., Drushlyak O.;O., Zhuravel I.;M., Kovalenko S.;S., Kovalenko S.; |
| Journal | anali mečnikìvsʹkogo institutu |
| Year | 2014 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.